Manchester, United Kingdom

Matiss Ozols

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: The Boots Company Plc. Active years: 2026.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matiss Ozols: Innovator in Tetrapeptide Research

Introduction

Matiss Ozols is a notable inventor based in Manchester, GB. He has made significant contributions to the field of biochemistry, particularly in the development of tetrapeptides. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Matiss Ozols holds a patent for "TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES." This patent highlights his research and development efforts in creating compositions that utilize tetrapeptides, which have various applications in the pharmaceutical and cosmetic industries. His work in this area is crucial for the advancement of therapeutic solutions.

Career Highlights

Ozols is currently employed at The Boots Company Plc, where he continues to explore the potential of tetrapeptides. His role at this prominent company allows him to collaborate with other experts in the field and contribute to innovative product development. His career is marked by a commitment to research and a passion for improving health outcomes through scientific innovation.

Collaborations

Matiss Ozols has worked alongside talented colleagues, including Michael David Bell and Eleanor Jane Bradley. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

In summary, Matiss Ozols is a dedicated inventor whose work in tetrapeptide research is paving the way for new advancements in the field. His contributions, along with his collaborations, reflect his commitment to innovation and excellence in science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…